P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1β.
Behavioral neuroscience
Biological sciences
Natural sciences
Neuroscience
Pharmacology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
02
08
2023
revised:
15
12
2023
accepted:
16
02
2024
medline:
6
3
2024
pubmed:
6
3
2024
entrez:
6
3
2024
Statut:
epublish
Résumé
Purinergic dysfunctions are associated with mania and depression pathogenesis. P2X7 receptor (P2X7R) mediates the IL-1β maturation via NLRP3 inflammasome activation. We tested in a mouse model of the subchronic amphetamine (AMPH)-induced hyperactivity whether P2X7R inhibition alleviated mania-like behavior through IL-1β. Treatment with JNJ-47965567, a P2X7R antagonist, abolished AMPH-induced hyperlocomotion in wild-type and IL-1α/β-knockout male mice. The NLRP3 inhibitor MCC950 failed to reduce AMPH-induced locomotion in WT mice, whereas the IL-1 receptor antagonist anakinra slightly increased it. AMPH increased IL-10, TNF-α, and TBARS levels, but did not influence BDNF levels, serotonin, dopamine, and noradrenaline content in brain tissues in either genotypes. JNJ-47965567 and P2rx7-gene deficiency, but not IL-1α/β-gene deficiency, attenuated AMPH-induced [
Identifiants
pubmed: 38444608
doi: 10.1016/j.isci.2024.109284
pii: S2589-0042(24)00505-4
pmc: PMC10914489
doi:
Types de publication
Journal Article
Langues
eng
Pagination
109284Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare no competing interests.